Uncategorized
Hereditary cancers aren’t just a women’s problem. Jewish men need to take precautions too.
Bill Harris, a veteran Los Angeles photojournalist, didn’t think much of it when one morning in 2012 he woke up and found a tiny blood spot on the T-shirt he’d slept in. The next morning, he found blood in the same place on his chest — and went straight to his computer.
“Online, I could find only three things that would cause a man’s nipple to discharge blood: being an avid runner, which I wasn’t; having a subtropical fungus, which I didn’t; and breast cancer,” he said. “That was a pretty big shock.”
Harris, then just a few weeks shy of his 61st birthday, immediately called his doctor, who ordered a mammogram and ultrasound. They confirmed a cancerous growth in his right breast. Ten days later, a biopsy came back positive. The next month Harris got a right mastectomy, followed by the removal of his left breast half a year later.
“I walked into a woman’s imaging center and had to get into a pink paper robe,” he recalled. “All the women in the waiting room were staring at me.”
Like many other Ashkenazi men, Harris never had considered that he might have been born with a harmful mutation of the BRCA gene, which elevates the risk not only of breast cancer, but also of melanoma and prostate, ovarian and pancreatic cancer.
“Hundreds of other mutations in the BRCA gene are just as dangerous, but they’re not specific to Ashkenazim,” said Dr. Robert Sidlow, director of the Male BRCA Genetic Risk Program at New York’s Memorial Sloan Kettering Cancer Center. About 1 in 40 Ashkenazi Jews (those of Eastern European descent) carries the harmful mutation, compared to about 1 in 400 in the general population.
“The vast majority of patients I see are relatives of women who have breast or ovarian cancer and then get tested,” he said. Of BRCA mutation carriers, Sidlow added, “Most men are pretty happy to enroll in some kind of surveillance program once they get over the initial shock.”
Sidlow is on the Men’s Leadership Council at Sharsheret, the national Jewish nonprofit organization that educates the community about cancer risks and supports those with breast cancer and ovarian cancer.
Elana Silber, CEO of Sharsheret (Hebrew for “chain”), says it’s crucial that men with a family history of cancer undergo genetic counseling screening for BRCA and other hereditary cancer mutations.
Genetic testing is possible via a standard blood or saliva sample.
While Sharsheret is primarily considered a women’s organization, it has been using November — nicknamed Movember for its focus on men’s health — for an awareness campaign focused on Jewish men’s cancer risks.
“This is not only a women’s issue,” Silber said. “Family history is so important. When a man shares his family history with his doctor, he may not realize that he should mention that his mother had breast cancer or that his sister had ovarian cancer, as these are not generally ‘men’s diseases.’ They are not aware that these cancers could mean that they themselves are at increased risk for cancer and that they can pass on these mutations to the next generation – their daughters and their sons.”
If someone discovers he (or she) is a carrier of one of the genetic mutations with elevated cancer risks — not just BRCA but also such mutations as ATM, TP53, CHEK2, and PALB2 — there are various precautions they can take for themselves and their children. They can monitor their own health more closely, they can get encourage their children to test to see if they are carriers and, for any future children, take steps to prevent the mutated genes from being passed down.
For example, couples can conceive via in vitro fertilization, or IVF, and then test the embryos before implantation to ensure that only those unaffected by the genetic mutation are implanted.
While most women are aware of the risks of breast cancer, men generally are not — even though the disease strikes 2,500 men in the U.S. every year and kills about 500 of them, according to Sidlow. About 1-2% of men with the BRCA1 mutation and 6-7% of men with the BRCA2 mutation will develop cancer by age 80.
“This is why we recommend periodic mammograms starting at about age 50 for men who carry a BRCA2 mutation,” Sidlow said. “We like to educate these men on how to check their chests once a month and have a clinician do a breast checkup on them once a year.”
Since the BRCA1 and BRCA2 mutations also make prostate cancer more likely, men with either mutation should get PSA (prostate-specific antigen) levels in their blood tested annually beginning at age 40, rather than 50, the age at which screening generally begins, Sidlow said.
Sharsheret has been promoting the importance of learning one’s family history, genetic counseling and screening among both men and women. The 20-year-old organization also runs various peer support networks, offers financial assistance to cancer patients, provides mental health counseling and guidance to patients, caregivers, and their friends, and seeks to educate the broader Jewish community about cancer risks and support.
Peggy Cottrell, a certified genetic counselor at Sharsheret, said men in general are more reluctant to get regular checkups than women.
Ashkenazi Jewish men are at elevated risk not just of breast and prostate cancer but also of pancreatic cancer. Pancreatic cancer is particularly difficult because it’s tough to detect early enough and hard to treat. The five-year survival rate is only 11%. About 2% of BRCA1 carriers and 4% of BRCA2 carriers will develop pancreatic cancer, Sidlow estimated.
“Usually by the time pancreas cancer is clinically detected it has already spread microscopically to the liver,” Sidlow said. “But pancreas cancer is potentially curable if caught when the tumor is extremely small.”
Even among those with elevated risks, certain behaviors can improve one’s odds, such as avoiding obesity, smoking and excessive alcohol consumption.
Harris, the California photojournalist, is still fighting at age 71. While he overcame breast cancer 10 years ago, last year he was diagnosed with ampullary cancer, a rare disease related to his BRCA2 status that was discovered thanks to his participation in a UCLA study. Surgeons have removed his gall bladder, half his pancreas and part of his small intestine, and he has had to endure eight rounds of chemotherapy.
“I’m still working through the aftereffects of the chemo. I have to eat smaller quantities than before and take enzymes to supplement my digestive processes,” Harris said.
Meanwhile, his 37-year-old son discovered that he, too, carries the BRCA2 mutation, and he had a double prophylactic mastectomy and reconstruction at age 30 — just to be on the safe side.
“If there’s any history of breast, ovarian or prostate cancer in your family, get tested genetically so that you’re informed,” Harris advised. “Diagnoses happen way too late for men, and the danger is too big.”
—
The post Hereditary cancers aren’t just a women’s problem. Jewish men need to take precautions too. appeared first on Jewish Telegraphic Agency.
Uncategorized
Anti-Israel Candidates for US Senate Boast Strong Polling Numbers in Michigan Democratic Primary
Mallory McMorrow, a Democrat running for US Senate in Michigan. Photo: Screenshot
Mallory McMorrow, a vocal critic of Israel’s war in Gaza and a candidate for the US Senate in Michigan, holds a narrow lead over the rest of the Democratic primary field, according to a new poll.
The Emerson College Polling/Nexstar Media survey shows McMorrow, a member of the Michigan state Senate, ahead of the pack with 22 percent of the vote. US Rep. Haley Stevens (D-MI) sits in second place with 17 percent of the vote. Abdul El-Sayed, a physician with an anti-Israel policy platform, holds a respectable 16 percent of the primary vote.
McMorrow’s lead over the field may spark consternation among supporters of Israel, whose defensive military campaign in Gaza has been characterized by McMorrow as tantamount to “genocide.”
Just days before the anniversary of Hamas’s Oct. 7, 2023, massacre across southern Israel, McMorrow called Israel’s response in Gaza a “moral abomination,” saying it was “just as horrendous” as the attack carried out by Hamas-led Palestinian terrorists, who perpetrated the deadliest massacre of Jews since the Holocaust.
However, in a recent interview, McMorrow indicated tentativeness over her previous condemnation of Israel, admitting that the word “genocide” has become a “purity test” among progressive activists in Democratic primaries.
“I am somebody who looks at the videos, the photos, the amount of pain that has been caused in the Middle East, and you can’t not be heartbroken,” McMorrow said during an interview earlier this month. “But I also feel like we are getting lost in this conversation, and it feels like a political purity test on a word — a word that, by the way, to people who lost family members in the Holocaust, does mean something very different and very visceral — and we’re losing sight of what I believe is a broadly shared goal among most Michiganders, that this violence needs to stop, that a temporary ceasefire needs to become a permanent ceasefire, that Palestinians deserve long term peace and security, that Israelis deserve long term peace and security, and that should be the role of the next US senator.”
Conversely, Stevens has established herself as the favorite among pro-Israel Michiganders. Stevens scored an endorsement from the Democratic Majority for Israel in November 2025. In a statement, DMFI praised Stevens as someone who has “stood firm against extremism, antisemitism, and efforts to undermine America’s alliances.”
Stevens has routinely touted her pro-Israel bona fides, vowing to stand beside the closest US ally in the Middle East despite mounting pressure by party activists to cut ties with the Jewish state. The lawmaker promised that if elected she would continue to support legislation which bolsters Israel’s security.
“As a proud pro-Israel Democrat, I believe America is stronger when we stand with our democratic allies, confront antisemitism and extremism, and keep our promises to our friends abroad and our working families here at home,” Stevens said in a statement. “In the Senate, I’ll keep fighting to protect our democracy, support Israel’s security, ensure the ceasefire holds in Gaza, and deliver for Michiganders in every corner of our state.”
El-Sayed, the most far-left candidate in the race, has been especially critical of Israel’s war in Gaza. On Oct. 21, 2023, two weeks after the Hamas-led slaughter of 1,200 people and kidnapping of 251 hostages in southern Israel, the progressive politician accused Israel of “genocide.” The comment came before the Israeli military launched its ground campaign in Gaza.
He also compared Israel’s defensive military operations to the Hamas terrorist group’s conduct on Oct. 7, writing, “You can both condemn Hamas terrorism AND Israel’s murder since.”
In comments to Politico, El-Sayed criticized Democrats’ handling of the Israeli-Palestinian conflict, arguing that they should become the “party of peace and justice” and said that they “ought not to be the party sending bombs and money to foreign militaries to drop bombs on other people’s kids in their schools and their hospitals.” He called on Democrats to stop supporting military aid for Israel, saying, “We should be spending that money here at home.”
Earlier this month, The Algemeiner reported that El-Sayed is facing scrutiny over his past fundraising and public support for a political advocacy group whose affiliates organized anti-Israel protests at Holocaust memorial sites in Washington, DC, and the Detroit metro area.
Uncategorized
Hamas Doubles Down on Refusal to Disarm as Trump Pushes Phase Two of Gaza Peace Plan
Palestinian Hamas terrorists stand guard at a site as Hamas says it continues to search for the bodies of deceased hostages, in Beit Lahiya in the northern Gaza Strip, Dec. 3, 2025. Photo: REUTERS/Stringer
As the United States and its allies prepare to roll out phase two of President Donald Trump’s Gaza peace plan, Hamas has doubled down on its refusal to disarm, clouding hopes for a breakthrough.
In an interview with the Qatari media network Al Jazeera on Wednesday, senior Hamas official Musa Abu Marzouk said the Palestinian terrorist group — which ruled Gaza before its war with Israel and still controls nearly half the enclave’s territory — never agreed to lay down its weapons under the ceasefire agreement.
“Not for a single moment did we talk about surrender the weapons, or any formula about destroying, surrendering, or disarmament,” the terrorist leader said, echoing repeated statements by Hamas officials saying they have no intention of disarming.
Abu Marzouk also reaffirmed that Hamas has moved to “restore order” in parts of the Gaza Strip from which Israeli forces withdrew as part of the ceasefire deal.
Currently, the Israeli military controls 53 percent of Gaza’s territory, and Hamas has moved to reestablish control over the rest. However, the vast majority of the Gazan population is located in the Hamas-controlled half, where the Islamist group has been imposing a brutal crackdown.
Disarmament “was never even presented to us,” Abu Marzouk told Al Jazeera.
“After a battle of this magnitude … and with the inability of Israel, America, and the West to disarm or destroy Hamas’s weapons, did they think they could obtain it through talks?” he continued.
The comments came one day before Trump said that Hamas would in fact give up its weapons.
“A lot of people said they’ll never disarm. It looks like they’re going to disarm,” Trump told a cabinet meeting on Thursday.
The US president also asked his special envoy, Steve Witkoff, for an update on the situation.
“We’ve got the terrorists out of there and they’re going to demilitarize. They will because they have no choice,” Witkoff said. “They’re going to give it up. They’re going to give up the AK-47s.”
Last week, Trump warned that Hamas “will be blown away very quickly” if it refuses to disarm and cooperate with the second phase of his administration’s 20-point peace plan.
According to multiple media reports, Washington is expected to announce a deadline in the coming days for the terrorist group to lay down its weapons, in an effort to set the terms of the disarmament process.
On Monday, Israeli Prime Minister Benjamin Netanyahu insisted that the next phase of the ceasefire deal would focus on disarming Hamas and demilitarizing the enclave, rather than on reconstruction.
“We are at the threshold of the next phase: Disarming Hamas and demilitarizing the Gaza Strip,” the Israeli leader told parliament, shortly after he officially announced that the remains of the last hostage had been recovered.
“The next phase is not reconstruction,” he continued. “We have an interest in advancing this phase, not delaying it. The sooner we do so, the sooner we will complete the objectives of the war.”
Under phase one of Trump’s peace plan, a ceasefire took effect and Hamas was required to release all remaining hostages, both living and deceased, who were kidnapped by Hamas-led Palestinian terrorists during the group’s invasion of and massacre across southern Israel on Oct. 7, 2023.
The body of the final hostage, Israeli police officer Ran Gvili, was returned on Monday, and he was buried on Wednesday.
In exchange for Hamas’s releasing nearly all the hostages, Israel freed thousands of Palestinian prisoners, including many serving life sentences for terrorism, and partially withdrew its military forces in Gaza to a newly drawn “Yellow Line,” roughly dividing the enclave between east and west.
The second stage of the US-backed peace plan is supposed to establish an interim administrative authority, a so-called “technocratic government,” deploy an International Stabilization Force (ISF) to oversee security in Gaza, and begin the demilitarization of Hamas.
In an effort to advance his regional peace initiative, Trump launched the so-called Board of Peace last week, inviting several countries — including Turkey — despite Israel’s opposition to its participation.
Israeli officials have repeatedly rejected any Turkish role in Gaza’s postwar reconstruction, warning that Ankara’s push to expand its regional influence could bolster Hamas’s terrorist infrastructure, as Turkey has been a longtime backer of the Islamist group.
Under Trump’s Gaza peace plan, the newly created Board of Peace will oversee the interim technocratic Palestinian government in the enclave, supported for at least two years by the ISF.
The ISF — comprising troops from multiple participating countries — will oversee the ceasefire deal between Israel and Hamas, train local security forces, secure Gaza’s borders with Israel and Egypt, and protect civilians while maintaining humanitarian corridors.
In addition, the ISF would seemingly be expected to take on the responsibility of disarming Hamas. Even though several countries — including Hamas backers Qatar and Turkey — have expressed interest in joining the international peacekeeping force, no final agreement has been reached.
Further Israeli military withdrawals in Gaza are tied to Hamas’s disarmament.
During his Wednesday interview, Abu Marzouk declared that “nobody can enter Gaza without understandings with Hamas,” emphasizing that the group will not give up control of the enclave.
“If Hamas doesn’t agree to the administrative committee, it cannot enter the Gaza Strip,” he told Al Jazeera, asserting that the group has the final say over who sits on it.
Trump’s peace plan, which has been endorsed by the United Nations, calls on Hamas to relinquish any governing role in Gaza.
Despite Hamas’s comments, the peace plan is moving forward with a transitional technocratic Palestinian administration in Gaza. The newly established 15-member body is led by Ali Shaath, a former deputy minister in the Palestinian Authority.
According to media reports, Hamas is looking to position around 10,000 members of its police force within the new Palestinian administration for Gaza.
Uncategorized
Forverts podcast, episode three: The cemetery
דער פֿאָרווערטס האָט שוין אַרויסגעלאָזט דעם דריטן קאַפּיטל פֿונעם ייִדישן פּאָדקאַסט, Yiddish With Rukhl. דאָס מאָל איז די טעמע „דער בית־עולם“. די פֿאַרגאַנגענע וואָך איז זי געווען „ליבע“. צו הערן ביידע קאַפּיטלען גיט אַ קוועטש דאָ.
אין דעם איצטיקן קאַפּיטל לייענט שׂרה־רחל שעכטער פֿאָר צוויי אַרטיקלען, „אַ טראַדיציאָנעלער מינהג געפֿירט פֿון פֿרויען: פֿעלדמעסטן און קנייטלעך לייגן“ פֿון אַנאַבעל כּהן, און „דאָס אַרײַנלייגן אין דר׳ערד: די פֿאַרשידענע ווערטער און אויסדרוקן פֿאַרן וואָרט ׳בית־עולם׳“ פֿון הערשל גלעזער.
אויב איר ווילט אויך לייענען דעם געדרוקטן טעקסט פֿון די אַרטיקלען, גיט אַ קוועטש דאָ און קוקט אונטן בײַם סוף פֿון דער זײַט.
אין דעם וואָכיקן פּאָדקאַסט לייענט די פֿאָרווערטס־רעדאַקטאָרין שׂרה־רחל שעכטער פֿאָר געקליבענע אַרטיקלען וואָס דער פֿאָרווערטס האָט געדרוקט במשך פֿון די יאָרן. דערווײַל איז דער פּאָדקאַסט בלויז אַ פּראָבע פֿון פֿינעף קאַפּיטלען. אויב ס׳וועט ווײַטער וואַקסן דער אינטערעס צו אים, וועט ער ווערן אַ געוויינטלעכער טייל פֿונעם פֿאָרווערטס.
טאָמער האָט איר קאָמענטאַרן אָדער פֿאָרלייגן, שרײַבט אַ בריוול דעם פֿאָרווערטס: schaechter@forward.com
The post Forverts podcast, episode three: The cemetery appeared first on The Forward.